Aldoxorubicin is a tumor-targeted doxorubicin conjugate designed for enhanced drug delivery. Utilizing an acid-sensitive EMCH linker, it enables precise tumor targeting, improving efficacy while reducing systemic toxicity, making it a promising advancement in cancer therapy. Reagent grade, for research use only.
Usually ships within 24 hours.